This study examines the use of process capability index results to establish sampling strategies for new product cleaning and to minimize the risk of insufficient cleaning.
Takashi Kaminagayoshi
Advertisement
Takashi Kaminagayoshi is director and head of Manufacturing Operations of Biologics & New Modalities Development, Pharmaceutical Sciences at Takeda Pharmaceutical Company Limited.
Articles by Takashi Kaminagayoshi
The approach presented in this study uses process capability index results to establish sampling strategies for use with new product cleaning and to efficiently reduce the risk of insufficient cleaning.
Advertisement
Latest Updated Articles
The Statistical Evaluation of Cleaning Processes Using Process Capability and its Application to New Product IntroductionPublished: May 2nd 2018 | Updated:
- Using Process Capability for Statistical Evaluation of Cleaning Processes
Published: June 7th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
3
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
4
New Targets for Clinical Trials in the European Union
5
